Descrizione del progetto
Un modo naturale per mantenere sani i polli
Salmonella ed Escherichia coli sono i patogeni infettivi più comuni nel pollame. Attualmente, per curare le infezioni negli allevamenti vengono comunemente somministrati antibiotici. Tuttavia, il loro uso eccessivo ha provocato un aumento della resistenza antimicrobica sia negli animali che nelle persone. Per mitigare tale effetto, il progetto PHAGOVET, finanziato dall’UE, propone biocidi economicamente vantaggiosi e additivi alimentari tecnologici a base di batteriofagi per colpire e uccidere i batteri. Sarà la prima soluzione a base di fagi a controllare naturalmente i due tipi di batteri nella produzione di pollame, evitando gli effetti collaterali e i residui associati all’uso di antibiotici. Questa alternativa naturale agli antibiotici gioverà alla produzione di pollame e uova dell’UE, tra le più vaste al mondo.
Obiettivo
The Phagovet project is devised to satisfy market demand for a more secure and reliable solution to control Salmonella and E. coli infections in poultry farms. With more than 40,000 poultry farms, the European Union (EU-28) is the forth world´s top producers in poultry meat (13.1 million tons, 2014) and the second largest egg producer (>11 million tons, 2014). The European poultry industry employs 302,000 staff across Europe and has an annual turnover of €30 B, being then of significant economic importance. To date, avian colibacillosis and salmonellosis are considered the main bacterial infections in the poultry sector having an important economic impact worldwide. Furthermore, EFSA estimated overall economic burden of human salmonellosis at €3B/year. Finally, the overuse of antibiotic in farming has caused a rise in antimicrobial resistance 700,000 people die annually from drug resistant infections and it is estimated that this number will rise to 10 million by 2050. In response to the unmet need, Phagovet proposes a cost-effective alternative to antibiotics against Salmonella and E. coli. Phagovet consists of a biocide and two technological food additive products based on selected bacteriophages able to kill the target bacteria. Phagovet will be the first phage-based solution to naturally and effectively control both bacteria in poultry production while avoiding side effects and residues associated to antibiotic use. It will reduce Sallmonella infections by 20% and reduce the use of antibiotics on E. coli by 50%. Thus, Phagovet provides a promising effective control measure for a concerning problem for poultry farmers and for human health. The successful market launch of Phagovet will enable members of the Consortium to consolidate their position in the Animal Health, Food Safety and Environmental Control markets and commercialize the product worldwide, reaching €17.76M profit at the end of 2026.
Campo scientifico
- medical and health scienceshealth sciencespublic health
- natural sciencesbiological sciencesmicrobiologybacteriology
- natural sciencesbiological sciencesmicrobiologyvirology
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsantibiotics
- medical and health sciencesbasic medicinepharmacology and pharmacydrug resistanceantibiotic resistance
Parole chiave
Programma(i)
Argomento(i)
Meccanismo di finanziamento
IA - Innovation actionCoordinatore
3460-021 Tondela
Portogallo
L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.